Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation.
Type IIB von Willebrand disease is characterized by enhanced ristocetin-induced platelet aggregation and absence of large von Willebrand factor multimers from plasma. An alteration of the von Willebrand factor molecule resulting in increased reactivity with platelets appears to be the basis for these abnormalities. We have now identified a new variant of type IIB von Willebrand disease in a family in which the four affected members also have chronic thrombocytopenia, in vivo platelet aggregate formation, and spontaneous platelet aggregation in vitro. In spite of repeatedly prolonged bleeding times and persistent thrombocytopenia, their bleeding diathesis is only moderate.
D000328:Adult; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D004587:Electrophoresis, Agar Gel; D005169:Factor VIII / Q000032:analysis; D005260:Female; D006801:Humans; D007123:Immunoelectrophoresis, Two-Dimensional; D008297:Male; D010375:Pedigree; D010974:Platelet Aggregation / Q000187:drug effects; D012310:Ristocetin / Q000494:pharmacology; D013921:Thrombocytopenia / Q000150:complications*; D014842:von Willebrand Diseases / Q000097:blood / Q000150:complications / Q000235:genetics*
D012310:Ristocetin; D005169:Factor VIII